患者称呼他们的吸入器与"喘发作"有关
Victoria E Forth1, Juan Carlos Cardet1, Ku-Lang Chang1
1From the Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA (VEF, BE, NEM, EI, PAH, JK, JRL, JC, JDS); Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL (JCC); Denver Health and Hospital Authority, Denver, CO (LPH); Lucas Research, Morehead City, NC (KLC); American Academy of Family Physicians National Research Network, Leawood, KS (EWS, JKC, BKM, WDP, JBS); University of Colorado Department of Family Medicine, Aurora, CO (EWS, JKC); Department of Internal Medicine, Allergy/Immunology Section, University of Puerto Rico, San Juan, PR (BTS); Division of Allergy and Immunology, Brigham and Women's Hospital, Boston, MA (EI); Pulmonary Science and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO (ALF); DARTNet Institute, Aurora, CO (WDP); Division of Immunology, Boston Children's Hospital, Boston, MA (WP); University of Miami Health System, Miami, FL (MF); Division of Allergy and Immunology, Department of Medicine, NorthShore University Health System, Glenview, IL (GM); Morehouse School of Medicine, Atlanta, GA (FO).
使用非标准喘吸入器名称的患者面临严重喘发作和住院住院的风险更高. 识别这些非标准名称可以帮助确定需要更多支持以更好地管理喘的个人.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床流行病学临床流行病学
- 卫生沟通健康沟通
背景情况:
- 临床医生和患者之间的错误沟通会对喘结果产生负面影响.
- 患者使用喘吸入器的术语及其与疾病严重程度的联系尚未得到充分理解.
研究的目的:
- 调查患者使用喘吸入器的名称与与喘相关的发病率之间的关系.
- 为了确定非标准的吸入器命名是否与喘恶化和医疗保健利用率的增加有关.
主要方法:
- 吸入器名称从中度至重度喘的黑人和拉丁人成年人中收集,并将其分类为标准 (品牌/通用/类型) 或非标准 (颜色/设备/独特名称).
- 评估了喘发病率,包括全身皮质类固醇爆发,急诊室 (ED) /急诊室 (UC) 访问,住院治疗,喘控制和生活质量.
- 采用多变量回归模型来分析非标准吸入器名称与喘发病率之间的关联.
主要成果:
- 近一半 (44%) 的参与者使用非标准的吸入器名称,这些人更有可能是黑人和来自东南地区.
- 使用非标准的吸入器名称与皮质类固醇爆发的增加率 (IRR=1.29),ED/UC访问 (IRR=1.43) 和喘住院 (OR=1.57) 显著相关.
- 使用非标准名称的参与者与使用标准名称的参与者相比,报告了更多的喘恶化.
结论:
- 使用非标准术语引用喘吸入器的患者经历了更大的喘发病率.
- 评估患者使用吸入器的名称可能作为快速查工具,以识别高风险个体,以改善喘护理.
相关概念视频
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction


